Vaccines against heart disease could be available within five year that reduces plaque by 60-70%

Next Big Future

• Working with Prof Prediman Shah, from Cedars-Sinai Heart Institute in Los Angeles, the team were able to formulate a vaccine that reduced plaque build up by 60 to 70 per cent in mice.
  
  The resulting CVX-210 vaccine, currently in development as an injection by CardioVax, is waiting regulatory clearance to start clinical trials.
• Knowing that the endothelial lining has been damaged before a blood clot grows might allow physicians to predict onset of a heart attack or stroke, said Zipes, who was not involved in the study.
  
  It could become possible to develop a wearable device for constantly monitoring the blood for endoteliel cells that indicate earlier damage of blood vessels.

Comment:

Lots of posts on health issues on that blog recently.